How To Use CPT Code 0700T

CPT 0700T describes the use of molecular fluorescent imaging to assess suspicious nevi for tissue changes and cell abnormalities. This article will cover the official description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples.

1. What is CPT Code 0700T?

CPT 0700T can be used to describe the application of fluorescent dye, special imaging device, and analysis software to evaluate a suspicious mole for tissue changes and cell abnormalities. This code specifically applies to the assessment of the first lesion.

2. Official Description

The official description of CPT code 0700T is: ‘Molecular fluorescent imaging of suspicious nevus; first lesion.’

3. Procedure

1. The healthcare provider administers a fluorescent peptide dye that binds to biomarker protein-receptors in the mole and surrounding area.
2. Using an imager, the provider excites the dye and captures fluorescence to identify tissue undergoing changes from benign to abnormal.
3. Analysis software may be utilized to assess the data and characteristics of the mole, such as size, shape, and color, to determine the likelihood of tissue changes.

4. Qualifying circumstances

CPT 0700T is applicable when there is a suspicious nevus that requires evaluation for tissue changes and cell abnormalities. The procedure involves the use of a fluorescent dye, special imaging device, and analysis software. It is important to note that this code is specifically for the assessment of the first lesion.

5. When to use CPT code 0700T

CPT code 0700T should be used when a healthcare provider performs molecular fluorescent imaging to assess a suspicious nevus for tissue changes and cell abnormalities. It is important to ensure that the procedure is being performed on the first lesion and not subsequent lesions. If there are additional lesions that require assessment, CPT code 0701T should be used.

6. Documentation requirements

To support a claim for CPT code 0700T, the healthcare provider must document the following information:

• Explanation of the need for molecular fluorescent imaging
• Details of the fluorescent dye used
• Date and time of the procedure
• Characteristics of the mole, such as size, shape, and color
• Analysis of the data and assessment of tissue changes
• Signature of the healthcare provider performing the procedure

7. Billing guidelines

When billing for CPT code 0700T, it is important to ensure that the procedure meets the criteria outlined in the official description. Additionally, it should be noted that CPT code 0700T is a Category III code, which is used to collect information about investigational technologies and procedures. It is recommended to use a Category III code when available instead of an unlisted procedure code. It is also important to review payer guidelines for reimbursement policies related to CPT code 0700T.

8. Historical information

CPT code 0700T was added to the Current Procedural Terminology system on January 1, 2022. As a relatively new code, there have been no updates or changes since its addition.

9. Examples

1. A dermatologist performs molecular fluorescent imaging on a suspicious nevus to assess tissue changes and cell abnormalities.
2. An oncologist utilizes fluorescent imaging to evaluate a mole for potential cancerous changes.
3. A plastic surgeon applies molecular fluorescent imaging to assess a suspicious nevus before performing a biopsy.
4. A dermatopathologist uses molecular fluorescent imaging to aid in the diagnosis of a challenging case.
5. A primary care physician refers a patient to a specialist for molecular fluorescent imaging to assess a suspicious mole.
6. An interventional radiologist performs molecular fluorescent imaging during a minimally invasive procedure to guide their interventions.
7. A cosmetic dermatologist uses molecular fluorescent imaging to assess the effectiveness of a treatment on a suspicious nevus.
8. An oncology nurse assists in the molecular fluorescent imaging procedure to ensure accurate assessment of a suspicious mole.
9. A research institution utilizes molecular fluorescent imaging to study the progression of tissue changes in suspicious nevi.
10. A healthcare provider performs molecular fluorescent imaging on a suspicious nevus as part of a clinical trial for a new diagnostic technique.